Skip to main content Back to Top
Advertisement

6/2/2022

Cetirizine Oral Solution

Products Affected - Description

    • Cetirizine hydrochloride oral solution, Camber, 1 mg/mL, 118 mL bottle, NDC 69230-0316-11
    • Cetirizine hydrochloride oral solution, Major, 1 mg/mL, 118 mL bottle, NDC 00904-6765-20
    • Cetirizine hydrochloride oral solution, Padagis, 1 mg/mL, 120 mL bottle, NDC 45802-0626-26
    • Cetirizine hydrochloride oral solution, Padagis, 1 mg/mL, 120 mL bottle, NDC 45802-0974-26

Reason for the Shortage

    • Camber did not provide a reason for the shortage.
    • Johnson & Johnson Consumer Healthcare has Children's Zyrtec Allergy oral solution available.
    • Major did not provide a reason for the shortage.
    • Padagis has cetirizine oral solution on shortage due to manufacturing delays and increased demand.
    • Precision Dose has cetirizine oral solution 5 mL cups available.
    • Additional over-the-counter cetirizine oral solution products may be available from store brands. These companies do not provide availability information.

Available Products

    • Children's Cetirizine hydrochloride oral solution, Precision Dose, 1 mg/mL, 5 mL cups bottle, 30 count, NDC 68094-0004-62
    • Children's Zyrtec Allergy oral solution, Johnson & Johnson Consumer Healthcare, 1 mg/mL, 118 mL grape bottle, NDC 50580-0730-05

Estimated Resupply Dates

    • Camber has cetirizine oral solution in 118 mL bottles on allocation.
    • Major has cetirizine oral solution in 118 mL bottles on back order and the company estimates a release date in mid-August 2022.
    • Padagis has cetirizine oral liquid in 120 mL bottles on allocation.

Updated

Created June 2, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.